Synergy Ventures

Synergy Ventures focuses on seed and early-stage investments in U.S. medical device startups, typically investing between $250,000 and $1 million initially. The firm seeks opportunities that can demonstrate clinical efficacy early and have strong potential for partnerships or acquisitions. Synergy Ventures has been active in the medtech sector since 1996, facilitating over $800 million in equity and other financial transactions for more than 70 private companies.

Notable portfolio companies include Neocis, Aria CV, and Paradromics. Key partners at Synergy Ventures leverage their extensive experience and networks to assist portfolio companies in forming strategic alliances, particularly with leading Japanese medical device corporations. This unique value-add service helps startups gain significant strategic advantages and access to new markets.